Lithosphere Deploys MultX to Enable Atomic Cross-Chain Execution on Makalu
American Aires Inc. Announces Change of Auditor
Zhibao Technology Announces 1H2026 Earnings Conference Call and Investor Webinar Participation
Integrated Quantum Technologies Announces Non-Brokered Private Placement of Units
TechCon Global Announces Dr. Irwin Jacobs as Recipient of the TechCon Fellows Lifetime Achievement Award
Objective of this partnership with Takanawa Japan K.K., Pharma Team, is to identify a strategic…
Financial report for the period 1 January 2021 to 31 March 2021 Operating profit decreased…
Press Release Nicox partners with Laboratorios Grin to bring ZERVIATETM to Mexico May 5, 2021…
Tecentriq significantly improved overall survival in people with high PD-L1 expression, compared with chemotherapy in…
Strong cash and cash equivalents position at March 31, 2021 of CHF25.2M ($26.7M) Completed $11.5M…
Saint-Herblain (France), May 5, 2021 – Valneva SE (the “Company”), a specialty vaccine company focused…
ROCKVILLE, Md., May 04, 2021 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical…
On track to refile Libervant™ (diazepam) Buccal Film New Drug Application (NDA) by end of…
BOTHELL, Wash., May 04, 2021 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a…
First-of-its-kind software predicts likelihood of off-target safety issues that could impede clinical progress PRINCETON, N.J.,…
Vertically-integrated cannabis leader finishes quarter with multiple post-merger successes and strong position for future expansion…
OXFORD, United Kingdom, May 04, 2021 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC), a clinical-stage…
Transformative, leading allogeneic NKT cell platform technology expands Athenex’s cell therapy development capability Platform has…
New Drug Application (NDA) submission for topical roflumilast cream as a potential treatment for plaque…
SAN CARLOS, Calif., May 04, 2021 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a…
Multiple pre-clinical studies indicate that Lixte’s lead clinical drug candidate LB-100 enhances the effectiveness of…
ERYTECH Provides Business Update and Reports Financial Results for the First Quarter of 2021 Conference…
SEATTLE, May 04, 2021 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company…
REDWOOD CITY, Calif., May 04, 2021 (GLOBE NEWSWIRE) — Seer, Inc., (Nasdaq: SEER), a life…
COPENHAGEN, Denmark, May 04, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical…